Therapieoptimierungsstudie für die Behandlung von Kindern mit Hochrisiko-Neuroblastom (NB 2004-HR)

Basic data for this project

Type of projectIndividual project
Duration at the University of Münster01/03/2017 - 30/06/2017

Description

Keywordspädiatrische Onkologie; Phase III Therapieoptimierungsstudie
Funder / funding scheme
  • Wirtschaft

Project management at the University of Münster

Faldum, Andreas
Institute of Biostatistics and Clinical Research (IBKF)

Applicants from the University of Münster

Faldum, Andreas
Institute of Biostatistics and Clinical Research (IBKF)

Research associates from the University of Münster

Gerß, Joachim
Institute of Biostatistics and Clinical Research (IBKF)
Schmidt, Rene
Institute of Biostatistics and Clinical Research (IBKF)